Advertisement

Reckitt Benckiser pays $1.4 billion in opioid settlement

July 11, 2019 12:23 PM

LONDON (AP) — Consumer products company Reckitt Benckiser says it will pay $1.4 billion to resolve U.S. investigations into the marketing of an anti-addiction drug by a subsidiary.

The company said Thursday it reached agreements with the U.S. Department of Justice and the Federal Trade Commission.

Advertisement – Content Continues Below

The government alleged that an ex-Reckitt subsidiary sought to increase prescriptions for Suboxone Film by deceiving health care providers into believing the drug was safer than other opioid addiction treatments.

Suboxone Film was marketed by RB's former prescription business Indivior, which was spun off in 2014.

The company says it "acted lawfully at all times and expressly denies all allegations that it engaged in any wrongful conduct" but the settlement was in the best interest of RB and shareholders.

It said the settlement would prevent uncertainty and distraction from continued investigations.

Credits

Copyright 2019 The Associated Press. All rights reserved.

Advertisement
Advertisement
Advertisement
Body found on the Hudson River in Cohoes

Deadly tractor-trailer crash ties up Northway traffic

Prosecutors drop groping case against Kevin Spacey

Myths and risks in app that gives you peek into older self

House set to block maverick Dem's Trump impeachment effort

Advertisement